Jill Wechsler, ACT's Washington Correspondent

Jill Wechsler is ACT's Washington Correspondent


A Defining Period for Future of FDA

June 22, 2022

Agency leaders seek to build public trust in science and gain support for regulation.

FDA User Fee Legislation Advances in Senate

June 17, 2022

Measure tackles infant formula, cosmetics, and diagnostics—plus drug development and access.

FDA to Continue Inspection Efficiencies After Pandemic

May 16, 2022

Plan to keep new methods adopted during COVID in place.

Congress Presses FDA on Key Policies and Operations

May 04, 2022

Medical device user-fees agreement, Aduhelm approval and access among issues in crosshairs.